WO2008048648A3 - Cb1-modulating compounds and their use - Google Patents
Cb1-modulating compounds and their use Download PDFInfo
- Publication number
- WO2008048648A3 WO2008048648A3 PCT/US2007/022183 US2007022183W WO2008048648A3 WO 2008048648 A3 WO2008048648 A3 WO 2008048648A3 US 2007022183 W US2007022183 W US 2007022183W WO 2008048648 A3 WO2008048648 A3 WO 2008048648A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- formula
- disclosed
- modulating compounds
- subject
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Addiction (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Abstract
Disclosed herein is a compound of Formula (I). Also disclosed herein is a method of modulating the activity of a cannabinoid receptor using a compound of Formula (I). Furthermore, disclosed herein is a method of treating a disease or condition that would be alleviated, improved or prevented by administration of a compound that modulates a cannabinoid receptor comprising identifying a subject in need thereof and administering to said subject a therapeutically effective amount of a compound of Formula (I). Also disclosed herein are pharmaceutical compositions comprising a compound of Formula (I).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85257906P | 2006-10-17 | 2006-10-17 | |
US60/852,579 | 2006-10-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008048648A2 WO2008048648A2 (en) | 2008-04-24 |
WO2008048648A3 true WO2008048648A3 (en) | 2008-06-12 |
Family
ID=39204737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2007/022183 WO2008048648A2 (en) | 2006-10-17 | 2007-10-17 | Cb1-modulating compounds and their use |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008048648A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2025674A1 (en) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs |
US8557738B2 (en) | 2008-08-12 | 2013-10-15 | Nippon Soda Co., Ltd. | Nitrogen-containing heterocyclic derivative and fungicide for agricultural and horticultural use |
KR101435729B1 (en) | 2009-09-28 | 2014-09-01 | 닛뽕소다 가부시키가이샤 | Nitrogen-containing heterocyclic compound and salt thereof, and bactericide for agricultural and horticultural use |
CN102807574B (en) * | 2011-05-30 | 2015-09-02 | 长春吉大天元化学技术股份有限公司 | New pyridine sulphur nitrogen seven-membered ring derivative as antitumor drug, and its preparation method and application |
ES2915101T3 (en) | 2014-03-27 | 2022-06-20 | Bird Rock Bio Inc | Antibodies that bind to the human cannabinoid receptor 1 (CB1) |
SG10202100916PA (en) | 2015-02-02 | 2021-02-25 | Valo Early Discovery Inc | 3-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors |
US10183934B2 (en) | 2015-02-02 | 2019-01-22 | Forma Therapeutics, Inc. | Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors |
MA43049A (en) | 2015-09-30 | 2018-08-08 | Bird Rock Bio Inc | HUMAN CANNABINOID 1 RECEPTOR BODY ANTIBODIES (CB1) |
EP3472131B1 (en) | 2016-06-17 | 2020-02-19 | Forma Therapeutics, Inc. | 2-spiro-5- and 6-hydroxamic acid indanes as hdac inhibitors |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005044822A1 (en) * | 2003-11-07 | 2005-05-19 | Pfizer Products Inc. | Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
-
2007
- 2007-10-17 WO PCT/US2007/022183 patent/WO2008048648A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005044822A1 (en) * | 2003-11-07 | 2005-05-19 | Pfizer Products Inc. | Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
Non-Patent Citations (1)
Title |
---|
HOWLETT A C ET AL: "Cannabinoid physiology and pharmacology: 30 years of progress", NEUROPHARMACOLOGY, PERGAMON PRESS, OXFORD, GB, vol. 47, 2004, pages 345 - 358, XP004612197, ISSN: 0028-3908 * |
Also Published As
Publication number | Publication date |
---|---|
WO2008048648A2 (en) | 2008-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008048648A3 (en) | Cb1-modulating compounds and their use | |
WO2007062078A3 (en) | Thrombopoietin activity modulating compounds and methods | |
MX2007004765A (en) | Thrombopoietin activity modulating compounds and methods. | |
UA107578C2 (en) | COMBINED DIABETES THERAPY | |
WO2007038669A3 (en) | Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors | |
EA201290078A1 (en) | HETEROCYCLIC COMPOUNDS TO INHIBIT PASK | |
WO2007044085A3 (en) | Heteroaryl compounds and their uses as therapeutic agents | |
WO2005075425A3 (en) | Substituted bisarylurea derivatives as kinase inhibitors | |
WO2011127333A3 (en) | Compounds for treating disease, for administering, and for pharmaceutical compositions | |
WO2007129195A3 (en) | 4-pyrimidine-5-amino-pyrazole compounds | |
SI2150530T1 (en) | Substituted sulfonamide derivatives | |
WO2008043544A8 (en) | Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators | |
WO2006020680A3 (en) | Heterocyclic compounds as pharmaceutical agents | |
WO2007138466A3 (en) | Pharmaceutical compositions comprising meloxicam and tramadol combination | |
TW200626158A (en) | Naphthaline derivatives | |
WO2006124413A3 (en) | Methods for treating drug resistant cancer | |
WO2009025785A3 (en) | Cb2 receptor ligands for the treatment of pain | |
MX2012014934A (en) | Cyclohexyl-azetidinyl antagonists of ccr2. | |
WO2008092072A3 (en) | Modulators of the metabotropic glutamate receptor subtype 5 and uses thereof | |
WO2010123959A3 (en) | 2,5-disubstituted arylsulfonamide ccr3 antagonists | |
WO2007128564A3 (en) | Use of a compound with rankl activity | |
WO2006079077A3 (en) | Use of diltiazem or analogs thereof as modulators of ghrelin receptor | |
WO2008074833A3 (en) | Compounds | |
WO2007098967A3 (en) | Imidazole compounds having pharmaceutical activity towards the sigma receptor | |
TW200800993A (en) | Organic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07839649 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07839649 Country of ref document: EP Kind code of ref document: A2 |